Andrew Kin

2 articles listing Andrew Kin in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study Nature Communications
2. TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial Nature Communications